Global Cell Isolation Market Size, Trends, and Analysis- Forecasts To 2026 By Product (Instruments, Consumables), By Application (Stem Cell Research, Biomolecule Isolation, Tissue Regeneration & Regenerative Medicine, Stem Cell Research, In Vitro Diagnostics), By Cell Source(Adipose Tissue, Bone Marrow, Cord Blood/ Embryonic Stem Cells), By Technique (Centrifugation-Based Cell Isolation, Filtration-Based Cell Isolation, Surface Marker-Based Cell Isolation), By Cell Type (Animal Cells, Human Cells), By End-User (Hospitals & Diagnostic Laboratories, Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
The method of removing individual living cells from a tissue or cell suspension cluster is called cell isolation. The major applications of this procedure are reduction of blood components from the blood sample, cord blood recovery of mononucleotide cells, bone marrow concentration, and other applications. The increasing investments in the cell-research and the growing incidence of infectious and chronic diseases around the globe are helping the market growthduring the forecast period. Also, the growing demand for customized medicines is expected to speed up the demand for the cell separation procedure. Furthermore, the risingadvancements in technology clubbed with the risingapplication of cell separation in producing regenerative medicineshave helped the market increase exponentially from 2020 to 2026.
Based on the application, the market can be bifurcated into stem cell research, biomolecule isolation, tissue regeneration & regenerative medicine, in-vitro diagnostics, and stem cell research. The major shareholder in terms of revenue in the market will be the biomolecule isolation application segment. This is mainly due to the increasing focus on the development of biopharmaceutical drugs, which include recombinant proteins, and monoclonal antibodies.
The segregation market as per the product-based outlook isconsumable and instruments. The largest market share in 2019 is the consumablessegment. This is due to the increasing investments in the production of technologically advanced products by government and private players.
According to the cell type, this market can be divided into two segments namely, animal cells and human cells. The human cell type would be the dominating segment as a segment as compared to the animal cell type segment. This is attributed to the growing advances in stem cell technologies for treating chronic to a rare type of human diseases.
This market can be divided into three segments based on the cell source: adipose tissue, cord blood/ embryonic stem cells, and bone marrow. In 2019, bone marrow is expected to be the largest shareholder. The commercialization of stem cell-based products derived from bone marrow, and the increasing number of surgeries and procedures related to cardiovascular diseases, tissue regeneration, and musculoskeletal disorders will help the market grow exponentially.
The segmentation of the market as per the end-user outlook are hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, research laboratories & institute. The biotechnology & biopharmaceutical companies would be the largest shareholder in the market due to the adoption of advanced instruments in cancer research and cell-based experiments in biopharmaceutical companies along with the rising number of R&D facilities around the globe.
Over the expected timeline, the North American region is projected to hold the largest market share in the region from 2020-2026. It is anticipated that the growing investment for R&D in regenerative medicine and the rising incidence of chronic infections will accelerate the development of this region's growth.On the other hand, the Asia-pacificregion will be the fastest-growing region mainly due to the availability of a vast genome pool, skilled professionals, and an increasing number of research activities taking place in Asian CROs.
The major players competing in this market are Thermo Fisher Scientific, Inc., Terumo BCT (Subsidiary Of Terumo Corporation), Merck Kgaa, MiltenyiBiotec, Stemcell Technologies, Bio-Techne, Becton, Dickinson And Company, Ge Healthcare, Corning Incorporation, Bio-Rad La, Roche Diagnostics (A Division Of F. Hoffman-La Roche Ltd.), Alfa Laval, Pluriselect Life Science Ug (Haftungsbeschränkt) & Co. Kg, Akadeum Life Sciences, Beckman Coulter Inc. (Subsidiary Of Danaher Corporation), and Biolegend, among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In May 2019, Beckman Coulter launched the ClearLLab 10C system for clinical cytometry applications.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Cell Isolation Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Cell Isolation Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?